# MRGPRF

## Overview
MRGPRF, or MAS-related G protein-coupled receptor family member F, is a gene that encodes a protein belonging to the G protein-coupled receptor (GPCR) family. This protein is classified as an orphan receptor due to the current lack of identified endogenous ligands. MRGPRF is predominantly expressed in enteroendocrine cells of the gut mucosa, particularly in the ileum and colon, where it is thought to play a role in neuro-immune communication and gastrointestinal physiology (Van2023The). Additionally, MRGPRF has been implicated in cutaneous melanoma as a tumor suppressor, where it interacts with the PI3K/Akt signaling pathway to inhibit tumor progression (Shen2022MrgprF). The gene's expression is often reduced in melanoma due to promoter hypermethylation, correlating with poorer clinical outcomes (Shen2022MrgprF). Despite its orphan status, MRGPRF's involvement in critical signaling pathways suggests its potential as a therapeutic target in cancer treatment and possibly other diseases.

## Function
The MRGPRF gene encodes a G protein-coupled receptor that is involved in cellular signaling processes. In healthy human cells, MRGPRF is predominantly expressed in enteroendocrine cells (EECs) of the gut mucosa, specifically in the ileum and colon. It is notably present in enterochromaffin cells (ECCs), a subset of EECs, where it co-expresses with serotonin (5-HT) and peptide YY (PYY) (Van2023The). This suggests a role in neuro-immune communication at mucosal surfaces, although its specific function in these cells remains to be fully elucidated (Van2023The).

MRGPRF is classified as an orphan receptor, as its ligands are currently unknown. Its expression in the gut mucosa indicates a potential involvement in modulating physiological responses related to the gastrointestinal tract, possibly influencing processes like serotonin signaling, which is crucial for gut motility and secretion (Van2023The). The absence of expression of other MRGPR family members in the mucosal biopsies suggests a unique role for MRGPRF in these tissues (Van2023The). Further research is encouraged to explore its role in both healthy and diseased states of the gut.

## Clinical Significance
The MRGPRF gene has been identified as a tumor suppressor in cutaneous melanoma (CM), a type of skin cancer. Its expression is often decreased in CM tissues and cell lines due to hypermethylation of its promoter region. This downregulation is associated with poor clinical outcomes, as patients with higher MRGPRF expression levels tend to have better survival rates (Shen2022MrgprF). The gene's tumor-suppressive role is linked to its ability to inhibit the PI3K/Akt signaling pathway, which is crucial for tumor progression. Overexpression of MRGPRF reduces tumor cell proliferation, migration, and metastasis, while its knockdown promotes these processes (Shen2022MrgprF).

In addition to its role in melanoma, MRGPRF is expressed in enteroendocrine cells of the human gut mucosa, suggesting potential involvement in gastrointestinal physiology and possibly in gastrointestinal cancers, although this requires further investigation (Van2023The). The orphan status of MRGPRF, due to unknown ligands, limits the full understanding of its clinical implications, but its expression in diverse tissues indicates a broader significance in human health and disease (Van2023The).

## Interactions
MRGPRF, a member of the MAS-related G protein-coupled receptor family, participates in several interactions that influence cellular signaling pathways. In cutaneous melanoma, MRGPRF acts as a tumor suppressor by interacting with components of the PI3K/Akt signaling pathway. Specifically, MRGPRF binds to the p110γ subunit of Class IB PI3K, inhibiting its interaction with the p101 subunit. This binding reduces the formation of the PI3K complex, thereby decreasing the conversion of phosphatidylinositol-(3, 4)-P2 (PIP2) to phosphatidylinositol-(3, 4, 5)-P3 (PIP3) and ultimately leading to reduced activation of the PI3K/Akt signaling pathway (Shen2022MrgprF).

MRGPRF's interaction with p110γ is specific, as it does not bind to the p85 subunit of Class IA PI3K, highlighting its selective role in modulating PI3K/Akt signaling (Shen2022MrgprF). This interaction is crucial for its function as a tumor suppressor, as it inhibits downstream effectors such as Akt, GSK3β, mTOR, and S6K, which are involved in cell proliferation and survival (Shen2022MrgprF). These interactions suggest that MRGPRF could be a potential therapeutic target in melanoma treatment.


## References


[1. (Shen2022MrgprF) Qiushuo Shen, Yanfei Han, Kai Wu, Yaomei He, Xiulin Jiang, Peishen Liu, Cuifeng Xia, Qiuxia Xiong, Rui Liu, Qianming Chen, Yong Zhang, Song Zhao, Cuiping Yang, and Yongbin Chen. Mrgprf acts as a tumor suppressor in cutaneous melanoma by restraining pi3k/akt signaling. Signal Transduction and Targeted Therapy, May 2022. URL: http://dx.doi.org/10.1038/s41392-022-00945-9, doi:10.1038/s41392-022-00945-9. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41392-022-00945-9)

[2. (Van2023The) Samuel Van Remoortel, Lana Lambeets, Heiko De Schepper, and Jean-Pierre Timmermans. The orphan mrgprf receptor is expressed in entero-endocrine cells of the human gut mucosa. Cell and Tissue Research, 393(2):393–399, June 2023. URL: http://dx.doi.org/10.1007/s00441-023-03797-z, doi:10.1007/s00441-023-03797-z. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00441-023-03797-z)